speb/financial-data huggingface dataset:
Financial ratios for TDUP — quarterly report dated 2025-03-31
Total revenue: 71291000
Gross profit: 56371000
Operating income: -5434000
Net income: -5215000
Capital expenditures: 1815000
Operating cash flow: 5743000
Depreciation & amortization: 3169000
Net tangible assets: 45337000
Owner earnings: -3861000
Return on net tangible assets (%): -8.516222952555308
Buffett classification: The Gruesome
Stock price: 2.41
Shares outstanding: 108372115
Book value: 56083000
P/B ratio: 4.656969084214468
Market cap (USD): 261176797.15
Debt to equity: 1.0126063156393204
Current ratio: 0.921576099382669
Quick ratio: 0.921576099382669
Interest coverage ratio: -10.571984435797665
COGS to revenue (%): 20.928307921055953
SG&A to revenue (%): 37.422676074118755
Free cash flow (dilution-adjusted): -1592000
Buyback yield (%): 0
Retained earnings: -561076000
Receivables turnover: 16.83774208786018
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.083493147481173
FCF margin (%): -2.2331009524343886
Rule of 40 score: -2.2331009524343886
Financial ratios for TDUP — quarterly report dated 2025-06-30
Total revenue: 77657000
Gross profit: 61736000
Operating income: -5245000
Net income: -5176000
Capital expenditures: 3279000
Operating cash flow: 344000
Depreciation & amortization: 3166000
Net tangible assets: 49461000
Owner earnings: -5289000
Return on net tangible assets (%): -10.693273488202827
Buffett classification: The Gruesome
Stock price: 7.49
Shares outstanding: 108372115
Book value: 60207000
P/B ratio: 13.48193966399256
Market cap (USD): 811707141.35
Debt to equity: 0.937615227465245
Current ratio: 0.9615183701897962
Quick ratio: 0.9615183701897962
Interest coverage ratio: -10.574596774193548
COGS to revenue (%): 20.50169334380674
SG&A to revenue (%): 37.930901270973635
Free cash flow (dilution-adjusted): -7435000
Buyback yield (%): 0
Retained earnings: -566252000
Receivables turnover: 20.441431955777837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.749615140813185
FCF margin (%): -9.57415300616815
Revenue growth (%): 8.929598406530978
Rule of 40 score: -0.6445545996371713
Financial ratios for TDUP — quarterly report dated 2025-09-30
Total revenue: 82161000
Gross profit: 65212000
Operating income: -4388000
Net income: -4248000
Capital expenditures: 3651000
Operating cash flow: 6028000
Depreciation & amortization: 3138000
Net tangible assets: 48326000
Owner earnings: -4761000
Return on net tangible assets (%): -9.85183958945495
Buffett classification: The Gruesome
Stock price: 9.45
Shares outstanding: 108372115
Book value: 59072000
P/B ratio: 17.33674984341143
Market cap (USD): 1024116486.7499999
Debt to equity: 0.9191833694474539
Current ratio: 0.923200170903653
Quick ratio: 0.923200170903653
Interest coverage ratio: -9.19916142557652
COGS to revenue (%): 20.62900889716532
SG&A to revenue (%): 37.79773858643395
Free cash flow (dilution-adjusted): -2062000
Buyback yield (%): 0
Retained earnings: -570500000
Receivables turnover: 22.056644295302014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.1034273156590455
FCF margin (%): -2.5097065517703046
Revenue growth (%): 5.799863502324324
Rule of 40 score: 3.290156950554019
Financial ratios for TDUP — quarterly report dated 2025-12-31
Total revenue: 79704000
Gross profit: 63434000
Operating income: -6679000
Net income: -5575000
Capital expenditures: 1727000
Operating cash flow: -1463000
Depreciation & amortization: 3451000
Net tangible assets: 48447000
Owner earnings: -3851000
Return on net tangible assets (%): -7.948892604289223
Buffett classification: The Gruesome
Stock price: 6.39
Shares outstanding: 108372115
Book value: 59193000
P/B ratio: 11.698981549338603
Market cap (USD): 692497814.85
Debt to equity: 0.8807122463804842
Current ratio: 0.9085604360371914
Quick ratio: 0.9085604360371914
Interest coverage ratio: -15.460648148148149
COGS to revenue (%): 20.413028204356117
SG&A to revenue (%): 35.69456990866205
Free cash flow (dilution-adjusted): -7734000
Buyback yield (%): 0
Retained earnings: -576075000
Receivables turnover: 32.705785802215836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.369141276879797
FCF margin (%): -9.70340258958145
Revenue growth (%): -2.990469930989155
Rule of 40 score: -12.693872520570606
Financial ratios for TDUP — annual report dated 2025-12-31
Total revenue: 310813000
Gross profit: 246753000
Operating income: -21746000
Net income: -20214000
Capital expenditures: 10472000
Operating cash flow: 10652000
Depreciation & amortization: 12924000
Net tangible assets: 48447000
Owner earnings: -17762000
Return on net tangible assets (%): -36.6627448552026
Buffett classification: The Gruesome
Stock price: 6.39
Shares outstanding: 108372115
Book value: 59193000
P/B ratio: 11.698981549338603
Market cap (USD): 692497814.85
Debt to equity: 0.8807122463804842
Current ratio: 0.9085604360371914
Quick ratio: 0.9085604360371914
Interest coverage ratio: -11.331943720687859
COGS to revenue (%): 20.61046352630038
SG&A to revenue (%): 37.205650986284354
Free cash flow (dilution-adjusted): -18823000
Buyback yield (%): 0
Retained earnings: -576075000
Receivables turnover: 127.53918752564628
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.73713822533734
FCF margin (%): -6.056052996496286
Revenue growth (%): 19.52920997881022
Rule of 40 score: 13.473156982313933
Financial ratios for TLSA — annual report dated 2021-12-31
Gross profit: 0
Capital expenditures: 29729.72972972973
Buffett classification: The Gruesome
Stock price: 0.96
Shares outstanding: 127259131
Market cap (USD): 122168765.75999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TLSA — annual report dated 2022-12-31
Total revenue: 0
Operating income: -17573493.975903615
Net income: -18550602.409638554
Capital expenditures: 0
Operating cash flow: -23632530.12048193
Depreciation & amortization: 61445.78313253012
Net tangible assets: 23579518.072289158
Owner earnings: -18489156.626506023
Return on net tangible assets (%): -78.41193602779623
Buffett classification: The Gruesome
Stock price: 0.6
Shares outstanding: 127259131
Book value: 23579518.072289154
P/B ratio: 3.238212009503858
Market cap (USD): 76355478.6
Debt to equity: 0.018650043431607994
Current ratio: 3.644304367402071
Quick ratio: 3.644304367402071
Interest coverage ratio: -383.84210526315786
Free cash flow (dilution-adjusted): -21933734.93975904
Buyback yield (%): 0
Retained earnings: -140075903.61445785
Receivables turnover: 0
Capitalized R&D asset: 15608433.73493976
ROCI (R&D-adjusted, %): -18.15537042123145
Rule of 40 score: 0
Financial ratios for TLSA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -22764556.962025315
Net income: -22393670.886075947
Capital expenditures: 0
Operating cash flow: -19870886.075949367
Depreciation & amortization: 121518.98734177214
Net tangible assets: 7007594.93670886
Owner earnings: -22272151.898734175
Return on net tangible assets (%): -317.8287572254335
Buffett classification: The Gruesome
Stock price: 0.56
Shares outstanding: 127259131
Book value: 7007594.93670886
P/B ratio: 10.169696451300581
Market cap (USD): 71265113.36
Debt to equity: 0.044617052023121384
Current ratio: 1.1220370087169294
Quick ratio: 1.1220370087169294
Interest coverage ratio: -1798.3999999999999
Free cash flow (dilution-adjusted): -22065822.784810126
Buyback yield (%): 0
Retained earnings: -169210126.58227846
Receivables turnover: 0
Capitalized R&D asset: 20727270.855574198
ROCI (R&D-adjusted, %): -75.77611159943535
Rule of 40 score: 0
Financial ratios for TLSA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4920000
Buffett classification: The Gruesome
Stock price: 0.7
Shares outstanding: 127259131
Book value: 4920000
P/B ratio: 18.10597392276423
Market cap (USD): 89081391.69999999
Debt to equity: 0.02693089430894309
Current ratio: 1.0217746325530757
Quick ratio: 1.0217746325530757
Buyback yield (%): 0
Retained earnings: -181038750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TLSA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -19742500
Net income: -14828750
Capital expenditures: 23750
Operating cash flow: -1907500
Depreciation & amortization: 155000
Net tangible assets: 4920000
Owner earnings: -14697500
Return on net tangible assets (%): -298.729674796748
Buffett classification: The Gruesome
Stock price: 0.7
Shares outstanding: 127259131
Book value: 4920000
P/B ratio: 18.10597392276423
Market cap (USD): 89081391.69999999
Debt to equity: 0.02693089430894309
Current ratio: 1.0217746325530757
Quick ratio: 1.0217746325530757
Interest coverage ratio: -2632.3333333333335
Free cash flow (dilution-adjusted): -3717500
Buyback yield (%): 0
Retained earnings: -181038750
Receivables turnover: 0
Capitalized R&D asset: 18567678.702150375
ROCI (R&D-adjusted, %): -102.22814395803397
Rule of 40 score: 0
Financial ratios for TLSA — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.58
Shares outstanding: 127259131
Market cap (USD): 201069426.98000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMHC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.96
Shares outstanding: 91999956
Market cap (USD): 3216318461.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMHC — annual report dated 2022-12-31
Total revenue: 8224917000
Gross profit: 2092366000
Operating income: 1449154000
Net income: 1056247000
Capital expenditures: 30581000
Operating cash flow: 1107772000
Depreciation & amortization: 33839000
Net tangible assets: 3967129000
Owner earnings: 1059505000
Return on net tangible assets (%): 26.70709724841315
Capex to operating income (%): 2.110265713650861
Buffett classification: The Great
Stock price: 30.35
P/E ratio: 2.643509202487676
Shares outstanding: 91999956
Book value: 4646859000
P/B ratio: 0.6008787149771491
Market cap (USD): 2792198664.6
Debt to equity: 0.5560820760862337
Current ratio: 7.683428029354096
Quick ratio: 1.7034093907722319
Effective tax rate (%): 24.156964115820273
Interest coverage ratio: 81.99354984723323
COGS to revenue (%): 74.56064298278025
SG&A to revenue (%): 7.8202856028820715
Free cash flow (dilution-adjusted): 1050290000
Buyback yield (%): 13.475939401106467
Retained earnings: 2741615000
Inventory turnover: 1.141815785730298
Receivables turnover: 42.949061116216896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.136841874513955
FCF margin (%): 12.769612143198527
Rule of 40 score: 12.769612143198527
Financial ratios for TMHC — annual report dated 2023-12-31
Total revenue: 7417831000
Gross profit: 1783073000
Operating income: 1084366000
Net income: 769741000
Capital expenditures: 33426000
Operating cash flow: 806169000
Depreciation & amortization: 33406000
Net tangible assets: 4651744000
Owner earnings: 769721000
Return on net tangible assets (%): 16.546933795152956
Capex to operating income (%): 3.082538552481358
Buffett classification: The Great
Stock price: 53.35
P/E ratio: 6.3764274640431005
Shares outstanding: 91999956
Book value: 5332286000
P/B ratio: 0.9204678167300103
Market cap (USD): 4908197652.6
Debt to equity: 0.39422135271814
Current ratio: 8.721079022579831
Quick ratio: 1.8331733116051567
Effective tax rate (%): 24.37490052444495
COGS to revenue (%): 75.96233993467902
SG&A to revenue (%): 9.419289816659344
Free cash flow (dilution-adjusted): 746648000
Buyback yield (%): 2.6070465995234886
Retained earnings: 3510544000
Inventory turnover: 1.0161054674412122
Receivables turnover: 40.20112400958172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.783750528156391
FCF margin (%): 10.065583861374032
Revenue growth (%): -9.812694766403114
Rule of 40 score: 0.25288909497091794
Financial ratios for TMHC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 70.26
Shares outstanding: 91999956
Market cap (USD): 6463916908.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMHC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.21
Shares outstanding: 91999956
Market cap (USD): 5631317306.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TMHC — annual report dated 2024-12-31
Total revenue: 8168136000
Gross profit: 1984212000
Operating income: 1213714000
Net income: 886570000
Capital expenditures: 36330000
Operating cash flow: 210079000
Depreciation & amortization: 41190000
Net tangible assets: 5203338000
Owner earnings: 891430000
Return on net tangible assets (%): 17.131887261600152
Capex to operating income (%): 2.993291665087492
Buffett classification: The Great
Stock price: 61.21
P/E ratio: 6.351802234183426
Shares outstanding: 91999956
Book value: 5878180000
P/B ratio: 0.9580035498674759
Market cap (USD): 5631317306.76
Debt to equity: 0.37417721131370596
Current ratio: 9.953092562386137
Quick ratio: 1.699263599966106
Effective tax rate (%): 23.314921141267586
COGS to revenue (%): 75.70789712610075
SG&A to revenue (%): 9.432972222793548
Free cash flow (dilution-adjusted): 151288000
Buyback yield (%): 6.1725877102100615
Retained earnings: 4393853000
Inventory turnover: 0.9919539101494301
Receivables turnover: 37.51962995457114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.209054611801797
FCF margin (%): 1.8521728825279111
Revenue growth (%): 10.114883986976785
Rule of 40 score: 11.967056869504697
Financial ratios for TMHC — quarterly report dated 2025-03-31
Total revenue: 1896019000
Gross profit: 463274000
Operating income: 286650000
Net income: 213731000
Capital expenditures: 8513000
Operating cash flow: 77231000
Depreciation & amortization: 9021000
Net tangible assets: 5282810000
Owner earnings: 214239000
Return on net tangible assets (%): 4.055398547363998
Capex to operating income (%): 2.9698238269666843
Buffett classification: The Great
Stock price: 60.04
P/E ratio: 6.4610156671704155
Shares outstanding: 91999956
Book value: 5957524000
P/B ratio: 0.9271766858580847
Market cap (USD): 5523677358.24
Debt to equity: 0.3623394551159173
Current ratio: 8.526259874369469
Quick ratio: 0.9700663843152184
Effective tax rate (%): 23.275382400769647
Interest coverage ratio: 33.72749735262972
COGS to revenue (%): 75.56596215544253
SG&A to revenue (%): 9.31551846263144
Free cash flow (dilution-adjusted): 60933000
Buyback yield (%): 2.445707655217655
Retained earnings: 4607319000
Inventory turnover: 0.22557819226335343
Receivables turnover: 8.93522498067824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3551555977549428
FCF margin (%): 3.213733617648346
Rule of 40 score: 3.213733617648346
Financial ratios for TMHC — quarterly report dated 2025-06-30
Total revenue: 2030070000
Gross profit: 467488000
Operating income: 284444000
Net income: 195985000
Capital expenditures: 7680000
Operating cash flow: -125957000
Depreciation & amortization: 10146000
Net tangible assets: 5384063000
Owner earnings: 198451000
Return on net tangible assets (%): 3.6858966917734803
Capex to operating income (%): 2.700004218756592
Buffett classification: The Great
Stock price: 61.42
P/E ratio: 13.791595391734763
Shares outstanding: 91999956
Book value: 6057862000
P/B ratio: 0.9327774877539303
Market cap (USD): 5650637297.52
Debt to equity: 0.35883699562650984
Current ratio: 9.427900263810736
Quick ratio: 1.3052488722808955
Effective tax rate (%): 25.5554331599959
COGS to revenue (%): 76.97182855763594
SG&A to revenue (%): 9.016634894363248
Free cash flow (dilution-adjusted): -141653000
Buyback yield (%): 1.769711887965077
Retained earnings: 4800896000
Inventory turnover: 0.24018062479652966
Receivables turnover: 8.423596876322625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.28848741533079
FCF margin (%): -6.977739683853266
Revenue growth (%): 7.070129571486361
Rule of 40 score: 0.09238988763309486
Financial ratios for TMHC — quarterly report dated 2025-09-30
Total revenue: 2095751000
Gross profit: 476621000
Operating income: 295920000
Net income: 204451000
Capital expenditures: 13047000
Operating cash flow: 219640000
Depreciation & amortization: 10405000
Net tangible assets: 5520932000
Owner earnings: 201809000
Return on net tangible assets (%): 3.6553429747006483
Capex to operating income (%): 4.408961881589619
Buffett classification: The Great
Stock price: 66.01
P/E ratio: 9.888055033175016
Shares outstanding: 91999956
Book value: 6197515000
P/B ratio: 0.9798955057890137
Market cap (USD): 6072917095.56
Debt to equity: 0.3652768892047861
Current ratio: 10.421456436931079
Quick ratio: 1.7480114867793672
Effective tax rate (%): 24.943189118743003
COGS to revenue (%): 77.25774674567732
SG&A to revenue (%): 8.622255220205071
Free cash flow (dilution-adjusted): 200057000
Buyback yield (%): 1.2276307880854622
Retained earnings: 5002337000
Inventory turnover: 0.25286721211216345
Receivables turnover: 7.879651840433132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3289385464804955
FCF margin (%): 9.545838222193382
Revenue growth (%): 3.2354056756663563
Rule of 40 score: 12.781243897859738
Financial ratios for TMHC — quarterly report dated 2025-12-31
Total revenue: 2099640000
Gross profit: 462825000
Operating income: 268203000
Net income: 177096000
Capital expenditures: 11132000
Operating cash flow: 646431000
Depreciation & amortization: 10610000
Net tangible assets: 5630125000
Owner earnings: 176574000
Return on net tangible assets (%): 3.1362358739814833
Capex to operating income (%): 4.150587428179402
Buffett classification: The Great
Stock price: 58.87
P/E ratio: 6.8448005400479985
Shares outstanding: 91999956
Book value: 6309289000
P/B ratio: 0.8584227810328549
Market cap (USD): 5416037409.719999
Debt to equity: 0.37446881891129097
Current ratio: 11.113459428941281
Quick ratio: 2.510645183434506
Effective tax rate (%): 22.263581135653336
COGS to revenue (%): 77.9569354746528
SG&A to revenue (%): 9.26930330913871
Free cash flow (dilution-adjusted): 628587000
Buyback yield (%): 1.317753084052086
Retained earnings: 5176353000
Inventory turnover: 0.26655346499229804
Receivables turnover: 8.687758091344682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9395330995177553
FCF margin (%): 29.937846487969367
Revenue growth (%): 0.1855659379382379
Rule of 40 score: 30.123412425907606
Financial ratios for TMHC — annual report dated 2025-12-31
Total revenue: 8121480000
Gross profit: 1870208000
Operating income: 1135217000
Net income: 791263000
Capital expenditures: 40372000
Operating cash flow: 817345000
Depreciation & amortization: 40182000
Net tangible assets: 5630125000
Owner earnings: 791073000
Return on net tangible assets (%): 14.050718234497458
Capex to operating income (%): 3.556324473646889
Buffett classification: The Great
Stock price: 58.87
P/E ratio: 6.8448005400479985
Shares outstanding: 91999956
Book value: 6309289000
P/B ratio: 0.8584227810328549
Market cap (USD): 5416037409.719999
Debt to equity: 0.37446881891129097
Current ratio: 11.113459428941281
Quick ratio: 2.510645183434506
Effective tax rate (%): 24.066185368550048
COGS to revenue (%): 76.97207898067839
SG&A to revenue (%): 9.049963799701533
Free cash flow (dilution-adjusted): 747924000
Buyback yield (%): 7.0349587932351065
Retained earnings: 5176353000
Inventory turnover: 1.0180125501106314
Receivables turnover: 33.604548200498186
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.442097764138536
FCF margin (%): 9.209208173879638
Revenue growth (%): -0.5711951906775303
Rule of 40 score: 8.638012983202108
Financial ratios for TXMD — annual report dated 2021-12-31
Gross profit: 1171000
Capital expenditures: 34000
Buffett classification: The Gruesome
Stock price: 18
Shares outstanding: 11574362
Market cap (USD): 208338516
Buyback yield (%): 0
Inventory turnover: 0.18394122277617422
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TXMD — annual report dated 2022-12-31
Total revenue: 2480957.45
Gross profit: 1083957.45
Operating income: -56819042.55
Net income: 111997000
Capital expenditures: 0
Operating cash flow: 9359000
Depreciation & amortization: 1200000
Net tangible assets: 28200000
Owner earnings: 113197000
Return on net tangible assets (%): 401.4078014184397
Buffett classification: The Gruesome
Stock price: 5.59
P/E ratio: 0.5777001489325607
Shares outstanding: 11574362
Book value: 35143000
P/B ratio: 1.841068878012691
Market cap (USD): 64700683.58
Debt to equity: 0.24923882423242183
Current ratio: 1.1817289011294008
Quick ratio: 1.1817289011294008
Effective tax rate (%): 0
COGS to revenue (%): 56.308906063665056
R&D to revenue (%): 0
SG&A to revenue (%): 2333.8973427375786
Free cash flow (dilution-adjusted): -2568000
Buyback yield (%): 59.74743675188849
Retained earnings: -939363000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -130.26213932002108
FCF margin (%): -103.5084257490994
Rule of 40 score: -103.5084257490994
Financial ratios for TXMD — annual report dated 2023-12-31
Total revenue: 1302000
Gross profit: 1302000
Operating income: -8523000
Net income: -10278000
Capital expenditures: 0
Operating cash flow: -23081000
Depreciation & amortization: 922000
Net tangible assets: 23189000
Owner earnings: -9356000
Return on net tangible assets (%): -40.346716115399545
Buffett classification: The Gruesome
Stock price: 2.25
Shares outstanding: 11574362
Book value: 29287000
P/B ratio: 0.8892107248950046
Market cap (USD): 26042314.5
Debt to equity: 0.27332946358452553
Current ratio: 1.7210388094543332
Quick ratio: 1.7210388094543332
COGS to revenue (%): 1.6897081413210446
SG&A to revenue (%): 683.7941628264208
Free cash flow (dilution-adjusted): -24352000
Buyback yield (%): 0
Retained earnings: -949641000
Receivables turnover: 0.42135922330097086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.379508983678505
FCF margin (%): -1870.353302611367
Revenue growth (%): -47.520260776741665
Rule of 40 score: -1917.8735633881088
Financial ratios for TXMD — quarterly report dated 2024-09-30
Gross profit: 547000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.66
Shares outstanding: 11574362
Market cap (USD): 19213440.919999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TXMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 11574362
Market cap (USD): 9953951.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TXMD — annual report dated 2024-12-31
Total revenue: 1761000
Operating income: -4844000
Net income: -2181000
Capital expenditures: 0
Operating cash flow: 1170000
Depreciation & amortization: 1280000
Net tangible assets: 23049000
Owner earnings: -901000
Return on net tangible assets (%): -3.9090632999262445
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 11574362
Book value: 27370000
P/B ratio: 0.3636810858604311
Market cap (USD): 9953951.32
Debt to equity: 0.26214833759590794
Current ratio: 2.373015873015873
Quick ratio: 2.373015873015873
COGS to revenue (%): 0
SG&A to revenue (%): 346.16695059625215
Free cash flow (dilution-adjusted): 906000
Buyback yield (%): 0
Retained earnings: -951822000
Receivables turnover: 0.4943851768669287
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.392678868552414
FCF margin (%): 51.4480408858603
Revenue growth (%): 35.25345622119816
Rule of 40 score: 86.70149710705846
Financial ratios for TXMD — quarterly report dated 2025-03-31
Total revenue: 393000
Operating income: -1193000
Net income: -653000
Capital expenditures: 0
Operating cash flow: 699000
Depreciation & amortization: 95000
Net tangible assets: 22602000
Owner earnings: -558000
Return on net tangible assets (%): -2.4688080700822934
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 11574362
Book value: 26740000
P/B ratio: 0.4025488653702318
Market cap (USD): 10764156.66
Debt to equity: 0.2606955871353777
Current ratio: 2.639105673908458
Quick ratio: 2.639105673908458
Interest coverage ratio: -596.5
COGS to revenue (%): 0
SG&A to revenue (%): 379.3893129770992
Free cash flow (dilution-adjusted): 676000
Buyback yield (%): 0
Retained earnings: -952475000
Receivables turnover: 0.13117489986648864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5617256306911482
FCF margin (%): 172.01017811704835
Rule of 40 score: 172.01017811704835
Financial ratios for TXMD — quarterly report dated 2025-06-30
Total revenue: 952000
Operating income: -695000
Net income: 551000
Capital expenditures: 0
Operating cash flow: 381000
Depreciation & amortization: 96000
Net tangible assets: 23249000
Owner earnings: 647000
Return on net tangible assets (%): 2.7829153942105034
Buffett classification: The Gruesome
Stock price: 1.16
P/E ratio: 6.091769473684209
Shares outstanding: 11574362
Book value: 27292000
P/B ratio: 0.49194855342224825
Market cap (USD): 13426259.92
Debt to equity: 0.2419756705261615
Current ratio: 2.8873873873873874
Quick ratio: 2.8873873873873874
Effective tax rate (%): 0
Interest coverage ratio: -347.5
COGS to revenue (%): 0
SG&A to revenue (%): 162.92016806722688
Free cash flow (dilution-adjusted): 380000
Buyback yield (%): 0
Retained earnings: -951924000
Receivables turnover: 0.2543414373497195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0536611311388215
FCF margin (%): 39.91596638655462
Revenue growth (%): 142.23918575063612
Rule of 40 score: 182.15515213719075
Financial ratios for TXMD — quarterly report dated 2025-09-30
Total revenue: 784000
Operating income: -830000
Net income: 152000
Capital expenditures: 0
Operating cash flow: 999000
Depreciation & amortization: 96000
Net tangible assets: 23530000
Owner earnings: 248000
Return on net tangible assets (%): 1.0539736506587336
Buffett classification: The Gruesome
Stock price: 1.08
P/E ratio: 250.0062192
Shares outstanding: 11574362
Book value: 27444000
P/B ratio: 0.45548429383471795
Market cap (USD): 12500310.96
Debt to equity: 0.23622649759510275
Current ratio: 2.932861476238625
Quick ratio: 2.932861476238625
Effective tax rate (%): 0
Interest coverage ratio: -276.6666666666667
COGS to revenue (%): 0
SG&A to revenue (%): 193.62244897959184
Free cash flow (dilution-adjusted): 999000
Buyback yield (%): 0
Retained earnings: -951772000
Receivables turnover: 0.21391541609822648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.461009310324379
FCF margin (%): 127.4234693877551
Revenue growth (%): -17.647058823529413
Rule of 40 score: 109.7764105642257
Financial ratios for TXMD — quarterly report dated 2025-12-31
Total revenue: 893000
Operating income: -1496000
Net income: -619000
Capital expenditures: 0
Operating cash flow: 375000
Depreciation & amortization: 906000
Net tangible assets: 23115000
Owner earnings: 287000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 11574362
Book value: 26876000
P/B ratio: 0.701972393957434
Market cap (USD): 18866210.06
Debt to equity: 0.22685667510046137
Current ratio: 3.018808777429467
Quick ratio: 3.018808777429467
COGS to revenue (%): 0
SG&A to revenue (%): 256.6629339305711
Free cash flow (dilution-adjusted): 324000
Buyback yield (%): 0
Retained earnings: -952391000
Receivables turnover: 0.25333333333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.551124091144169
FCF margin (%): 36.28219484882419
Revenue growth (%): 13.903061224489797
Rule of 40 score: 50.18525607331399
Financial ratios for TXMD — annual report dated 2025-12-31
Total revenue: 3022000
Operating income: -4214000
Net income: -569000
Capital expenditures: 0
Operating cash flow: 2454000
Depreciation & amortization: 1193000
Net tangible assets: 23115000
Owner earnings: 624000
Buffett classification: The Gruesome
Stock price: 1.63
Shares outstanding: 11574362
Book value: 26876000
P/B ratio: 0.701972393957434
Market cap (USD): 18866210.06
Debt to equity: 0.22685667510046137
Current ratio: 3.018808777429467
Quick ratio: 3.018808777429467
COGS to revenue (%): 0
SG&A to revenue (%): 226.73726009265386
Free cash flow (dilution-adjusted): 2379000
Buyback yield (%): 0
Retained earnings: -952391000
Receivables turnover: 0.8573049645390071
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.819810775455567
FCF margin (%): 78.72270019854402
Revenue growth (%): 71.60704145371948
Rule of 40 score: 150.3297416522635
Financial ratios for UPL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.660029012264275
Shares outstanding: 844169318
Market cap (USD): 8154700103.143347
Buyback yield (%): 0
Retained earnings: 2030199129.6320717
Capitalized R&D asset: 13187392.852433074
Rule of 40 score: 0
Financial ratios for UPL.NS — annual report dated 2023-03-31
Total revenue: 6471863580.998782
Gross profit: 3107551766.1388555
Operating income: 1065773447.0158345
Net income: 537637028.0146164
Capital expenditures: 195006090.13398296
Operating cash flow: 944092570.0365409
Depreciation & amortization: 310231425.09135205
Net tangible assets: -172959805.11571255
Owner earnings: 652862362.9719856
Return on net tangible assets (%): -377.4647887323944
Capex to operating income (%): 18.297142857142855
Buffett classification: The Great
Stock price: 8.431303288672352
P/E ratio: 13.238387938667422
Shares outstanding: 844169318
Book value: 4315347137.637028
P/B ratio: 1.6493337198701068
Market cap (USD): 7117447547.049696
Debt to equity: 0.6756894069829802
Current ratio: 1.4473947033095707
Quick ratio: 0.965767813479354
Effective tax rate (%): 14.29126213592233
Interest coverage ratio: 2.9323056300268098
COGS to revenue (%): 51.98366394399066
R&D to revenue (%): 0.2296081604998683
SG&A to revenue (%): 4.44160048180073
Free cash flow (dilution-adjusted): 640438489.6467723
Buyback yield (%): 2.318845763834166
Retained earnings: 2477588306.942753
Inventory turnover: 1.9750446907400787
Receivables turnover: 2.9063559785581448
Capitalized R&D asset: 23695480.12952237
ROCI (R&D-adjusted, %): 14.723883118235703
FCF margin (%): 9.895735310723829
Rule of 40 score: 9.895735310723829
Financial ratios for UPL.NS — annual report dated 2024-03-31
Total revenue: 5108406283.727065
Gross profit: 2138385897.589639
Operating income: 341527761.12243676
Net income: -143902146.54035255
Capital expenditures: 134068833.19342847
Operating cash flow: 278330735.1001319
Depreciation & amortization: 331334692.40916175
Net tangible assets: -409401606.90730304
Owner earnings: 53363712.67538072
Capex to operating income (%): 39.25561797752809
Buffett classification: The Good
Stock price: 5.359404990403071
Shares outstanding: 844169318
Book value: 3922053003.9573097
P/B ratio: 1.1535400595222558
Market cap (USD): 4524245255.634357
Debt to equity: 0.9097413318657126
Current ratio: 1.4641301515207923
Quick ratio: 0.9884963329734561
Interest coverage ratio: 0.8431024274718768
COGS to revenue (%): 58.1398624380854
R&D to revenue (%): 0.2934341181717881
SG&A to revenue (%): 4.647996431841124
Free cash flow (dilution-adjusted): 38253987.28864372
Buyback yield (%): 0
Retained earnings: 2181196786.185394
Inventory turnover: 1.9385566687539133
Receivables turnover: 2.5538968824940045
Capitalized R&D asset: 29297797.607912414
ROCI (R&D-adjusted, %): 4.68308426683371
Rosenberg metric: -65.2200965638448
FCF margin (%): 0.7488438695744031
Revenue growth (%): -21.067460403133204
Rule of 40 score: -20.3186165335588
Financial ratios for UPL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -516602962.2551362
Buffett classification: The Gruesome
Stock price: 7.187768752986145
Shares outstanding: 844169318
Book value: 3776397515.5279512
P/B ratio: 1.6067412980759106
Market cap (USD): 6067693846.150024
Debt to equity: 1.0506389170040484
Current ratio: 1.353354106228287
Quick ratio: 0.8481429748218188
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UPL.NS — quarterly report dated 2024-12-31
Total revenue: 1271360298.4030771
Gross profit: 650192330.1084042
Operating income: 169600186.5019233
Net income: 99428837.85989042
Capital expenditures: 0
Depreciation & amortization: 80195827.01946613
Owner earnings: 179624664.87935656
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.7314372304464385
P/E ratio: 12.165241900955452
Shares outstanding: 844169318
Market cap (USD): 4838303457.985779
Effective tax rate (%): -140.96045197740114
Interest coverage ratio: 1.7572463768115942
COGS to revenue (%): 48.85853121848354
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UPL.NS — quarterly report dated 2025-03-31
Total revenue: 1820551788.636895
Gross profit: 820902501.7535655
Operating income: 298339957.91442597
Net income: 126139817.62917933
Capital expenditures: 0
Depreciation & amortization: 82417582.41758241
Net tangible assets: 71896188.91746551
Owner earnings: 208557400.04676175
Return on net tangible assets (%): 290.0813008130081
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.28719803944451
P/E ratio: 12.192083980121797
Shares outstanding: 844169318
Book value: 4422024783.726912
P/B ratio: 1.3911339940307108
Market cap (USD): 6151628999.088809
Debt to equity: 0.6635383069846137
Current ratio: 1.388253001505128
Quick ratio: 1.0271623087962476
Effective tax rate (%): 21.64124909222948
Interest coverage ratio: 2.7921225382932167
COGS to revenue (%): 54.90913760996597
Buyback yield (%): 0
Retained earnings: 2439560439.5604396
Inventory turnover: 0.8289065529274914
Receivables turnover: 0.9736776291109166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.293910790301684
Revenue growth (%): 43.1971559064447
Rule of 40 score: 43.1971559064447
Financial ratios for UPL.NS — annual report dated 2025-03-31
Total revenue: 5408230067.804536
Gross profit: 2541033434.650456
Operating income: 657002571.8961889
Net income: 104863221.88449848
Capital expenditures: 43605330.83937339
Operating cash flow: 1186696282.4409633
Depreciation & amortization: 321487023.61468315
Net tangible assets: 71896188.91746551
Owner earnings: 382744914.6598082
Return on net tangible assets (%): 532.3577235772358
Capex to operating income (%): 6.637010676156583
Buffett classification: The Great
Stock price: 7.28719803944451
P/E ratio: 58.66336060000633
Shares outstanding: 844169318
Book value: 4422024783.726912
P/B ratio: 1.3911339940307108
Market cap (USD): 6151628999.088809
Debt to equity: 0.6635383069846137
Current ratio: 1.388253001505128
Quick ratio: 1.0271623087962476
Effective tax rate (%): 1.085645355850422
Interest coverage ratio: 1.7388613861386137
COGS to revenue (%): 53.015433833383774
R&D to revenue (%): 0.2334529419393887
SG&A to revenue (%): 4.018416843197441
Free cash flow (dilution-adjusted): 983984101.0053775
Buyback yield (%): 0
Retained earnings: 2439560439.5604396
Inventory turnover: 2.37747188832881
Receivables turnover: 2.8924596723771416
Capitalized R&D asset: 27572618.727171816
ROCI (R&D-adjusted, %): 9.39667494532427
Rosenberg metric: 26.861422492401225
FCF margin (%): 18.194198262072543
Revenue growth (%): 5.869223539101926
Rule of 40 score: 24.06342180117447
Financial ratios for UPL.NS — quarterly report dated 2025-06-30
Total revenue: 1078399251.1116312
Gross profit: 590568687.1050785
Operating income: 89398549.02878541
Net income: -10297215.071378423
Capital expenditures: 0
Depreciation & amortization: 85537093.3770185
Owner earnings: 75239878.30564007
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.5938450737186995
P/E ratio: 29.778641348989414
Shares outstanding: 844169318
Market cap (USD): 6410491016.878775
Interest coverage ratio: 1.0380434782608696
COGS to revenue (%): 45.23654513888889
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -40.765252719393224
Rule of 40 score: -40.765252719393224
Financial ratios for UPL.NS — quarterly report dated 2025-12-31
Total revenue: 1366714938.175337
Gross profit: 715495154.2831681
Operating income: 186142363.81864765
Net income: 54583936.72719172
Capital expenditures: 0
Depreciation & amortization: 92124317.70079091
Owner earnings: 146708254.42798263
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.7727525899521
P/E ratio: 27.443175856623924
Shares outstanding: 844169318
Market cap (USD): 7405688570.842598
Effective tax rate (%): 26.97466467958271
Interest coverage ratio: 2.387142857142857
COGS to revenue (%): 47.648545113701196
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 26.735523672378807
Rule of 40 score: 26.735523672378807
Financial ratios for VIDYAWIRES.NS — quarterly report dated 2025-12-31
Total revenue: 49923359.697003454
Gross profit: 3248078.4226356247
Operating income: 2525008.354684193
Net income: 1717945.8616464299
Capital expenditures: 0
Depreciation & amortization: 101370.16820764175
Owner earnings: 1819316.0298540716
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5541940514648547
P/E ratio: 20.190744694756702
Shares outstanding: 212692307
Market cap (USD): 117872811.33173667
Effective tax rate (%): 25.306339904102288
Interest coverage ratio: 8.479985035540592
COGS to revenue (%): 93.49387052003517
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.135198417046376
Rule of 40 score: 4.135198417046376
Financial ratios for VITA.V — annual report dated 2022-03-31
Total revenue: 5837664.8
Gross profit: 1188802.4
Operating income: -7168494.4
Net income: -8174226.4
Capital expenditures: 32049.6
Operating cash flow: -10428143.2
Depreciation & amortization: 784012.8
Net tangible assets: -3420153.6
Owner earnings: -7422263.2
Buffett classification: The Gruesome
Stock price: 4.720000000000001
Shares outstanding: 66663533
Book value: 3881131.200000001
P/B ratio: 81.07220795833956
Market cap (USD): 314651875.76000005
Debt to equity: 1.1568087159743528
Current ratio: 0.8202447903295257
Quick ratio: 0.41449998665987936
Interest coverage ratio: -7.6581569557507
COGS to revenue (%): 79.63565157081305
SG&A to revenue (%): 105.73837675640438
Free cash flow (dilution-adjusted): -10591456
Buyback yield (%): 0
Retained earnings: -30842560.8
Inventory turnover: 2.530559437301017
Receivables turnover: 9.537333993807403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -108.71974105132018
FCF margin (%): -181.43309632988863
Rule of 40 score: -181.43309632988863
Financial ratios for VITA.V — annual report dated 2023-03-31
Total revenue: 5603982.962962963
Gross profit: -3094705.185185185
Operating income: -12107712.592592591
Net income: -20795082.22222222
Capital expenditures: 0
Operating cash flow: -5394647.407407407
Depreciation & amortization: 111802.96296296295
Net tangible assets: -16715406.666666666
Owner earnings: -20683279.259259257
Buffett classification: The Gruesome
Stock price: 0.4444444444444444
Shares outstanding: 66663533
Book value: -16715406.666666664
Market cap (USD): 29628236.888888888
Debt to equity: -0.5721835951831354
Current ratio: 0.1025108512728783
Quick ratio: 0.07800755607407205
Interest coverage ratio: -6.925599454948512
COGS to revenue (%): 155.22331537476586
SG&A to revenue (%): 99.79374458140023
Free cash flow (dilution-adjusted): -5444396.296296296
Buyback yield (%): 0
Retained earnings: -49353008.88888889
Inventory turnover: 24.62233558521724
Receivables turnover: 18.101023320804014
Capitalized R&D asset: 0
FCF margin (%): -97.15226352896887
Revenue growth (%): -4.003001971559537
Rule of 40 score: -101.15526550052842
Financial ratios for VITA.V — annual report dated 2024-03-31
Total revenue: 1431422.962962963
Gross profit: 519886.6666666666
Operating income: -3235463.7037037034
Net income: 3090299.259259259
Capital expenditures: 0
Operating cash flow: -2751534.0740740737
Depreciation & amortization: 0
Net tangible assets: -7410851.851851852
Owner earnings: 3090299.259259259
Return on net tangible assets (%): -41.699649662906744
Buffett classification: The Gruesome
Stock price: 0.16176470588235292
P/E ratio: 3.48956715972174
Shares outstanding: 66663533
Book value: -7410851.851851853
Market cap (USD): 10783806.808823528
Debt to equity: -0.9205391492955773
Current ratio: 0.18191125021848376
Quick ratio: 0.18191125021848376
Effective tax rate (%): 0
Interest coverage ratio: -2.3990025841638265
COGS to revenue (%): 63.68042988562016
SG&A to revenue (%): 221.97968248119847
Free cash flow (dilution-adjusted): -2728703.7037037034
Buyback yield (%): 0
Retained earnings: -46262709.62962963
Receivables turnover: 3.4828248711797754
Capitalized R&D asset: 0
FCF margin (%): -190.6287501533051
Revenue growth (%): -74.45704292066344
Rule of 40 score: -265.08579307396855
Financial ratios for VITA.V — quarterly report dated 2024-09-30
Operating income: -336778.5185185185
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.37037037037037035
Shares outstanding: 66663533
Market cap (USD): 24690197.407407407
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VITA.V — quarterly report dated 2024-12-31
Total revenue: 866860.1398601399
Gross profit: 379325.17482517485
Operating income: -363672.7272727273
Net income: -519752.44755244756
Capital expenditures: 0
Operating cash flow: -600276.9230769231
Net tangible assets: -8547904.195804195
Owner earnings: -519752.44755244756
Buffett classification: The Gruesome
Stock price: 0.5104895104895105
Shares outstanding: 66663533
Book value: -8547904.195804197
Market cap (USD): 34031034.32867133
Debt to equity: -0.8838187383763884
Current ratio: 0.07543190937956643
Quick ratio: 0.07343943859249963
Interest coverage ratio: -1.4605289394530867
COGS to revenue (%): 56.241479174901784
SG&A to revenue (%): 75.17856422584522
Free cash flow (dilution-adjusted): -675323.076923077
Buyback yield (%): 0
Retained earnings: -45141352.44755245
Inventory turnover: 26.46628957558272
Receivables turnover: 2.089305458173777
Capitalized R&D asset: 0
FCF margin (%): -77.9045022224732
Rule of 40 score: -77.9045022224732
Financial ratios for VITA.V — annual report dated 2025-03-31
Total revenue: 3322938.4615384615
Gross profit: 1095292.3076923077
Operating income: -1406290.2097902098
Net income: -2505204.8951048953
Capital expenditures: 0
Operating cash flow: -1053983.216783217
Net tangible assets: -9382055.944055945
Owner earnings: -2505204.8951048953
Buffett classification: The Gruesome
Stock price: 0.30069930069930073
Shares outstanding: 66663533
Book value: -9382055.944055945
Market cap (USD): 20045677.755244758
Debt to equity: -0.8000196029617614
Current ratio: 0.07754256030044837
Quick ratio: 0.07581904698452549
Interest coverage ratio: -1.4545023868074642
COGS to revenue (%): 67.03844141654051
SG&A to revenue (%): 66.28331736044558
Free cash flow (dilution-adjusted): -1254106.293706294
Buyback yield (%): 0
Retained earnings: -46179790.909090914
Inventory turnover: 127.08078350021941
Receivables turnover: 7.818691598011679
Capitalized R&D asset: 0
FCF margin (%): -37.74088230107232
Revenue growth (%): 132.14231904315483
Rule of 40 score: 94.40143674208251
Financial ratios for VITA.V — quarterly report dated 2025-03-31
Total revenue: 480865.73426573427
Gross profit: 11023.776223776224
Operating income: -604521.6783216783
Net income: -1038438.4615384616
Capital expenditures: 0
Operating cash flow: -294384.6153846154
Net tangible assets: -9382055.944055945
Owner earnings: -1038438.4615384616
Buffett classification: The Gruesome
Stock price: 0.30069930069930073
Shares outstanding: 66663533
Book value: -9382055.944055945
Market cap (USD): 20045677.755244758
Debt to equity: -0.8000196029617614
Current ratio: 0.07754256030044837
Quick ratio: 0.07581904698452549
Interest coverage ratio: -2.4149658343623064
COGS to revenue (%): 97.70751470977463
SG&A to revenue (%): 115.04905197211323
Free cash flow (dilution-adjusted): -369430.76923076925
Buyback yield (%): 0
Retained earnings: -46179790.909090914
Inventory turnover: 26.8031276179838
Receivables turnover: 1.1314506482116795
Capitalized R&D asset: 0
FCF margin (%): -76.82617889063724
Revenue growth (%): -44.52787570284203
Rule of 40 score: -121.35405459347928
Financial ratios for VITA.V — quarterly report dated 2025-06-30
Total revenue: 1218835.7664233577
Gross profit: 326533.57664233574
Operating income: -507870.0729927007
Net income: -339071.5328467153
Capital expenditures: 0
Operating cash flow: -1871436.4963503648
Net tangible assets: -8492517.518248174
Owner earnings: -339071.5328467153
Buffett classification: The Gruesome
Stock price: 0.5547445255474452
Shares outstanding: 66663533
Book value: -8492517.518248174
Market cap (USD): 36981229.98540146
Debt to equity: -0.9241587420579508
Current ratio: 0.27684352568972753
Quick ratio: 0.2567148803283381
Interest coverage ratio: -1.6335748463348092
COGS to revenue (%): 73.2093867247972
SG&A to revenue (%): 59.80806142034548
Free cash flow (dilution-adjusted): -1949770.0729927006
Buyback yield (%): 0
Retained earnings: -48541335.03649635
Inventory turnover: 4.173779145000324
Receivables turnover: 1.1647107239138852
Capitalized R&D asset: 0
FCF margin (%): -159.9698767221322
Revenue growth (%): 153.4669616841131
Rule of 40 score: -6.502915038019097
Financial ratios for VITA.V — quarterly report dated 2025-09-30
Total revenue: 1523138.8489208634
Gross profit: 554635.2517985612
Operating income: -352430.21582733816
Net income: 109493.52517985612
Capital expenditures: 0
Operating cash flow: 86135.9712230216
Net tangible assets: -8116722.302158274
Owner earnings: 109493.52517985612
Return on net tangible assets (%): -1.3489869568500734
Buffett classification: The Gruesome
Stock price: 0.8129496402877697
P/E ratio: 123.73812762818996
Shares outstanding: 66663533
Book value: -8116722.302158274
Market cap (USD): 54194095.17266186
Debt to equity: -0.9410943425793663
Current ratio: 0.43480333618276723
Quick ratio: 0.4270121501760472
Interest coverage ratio: -1.0215432481070679
COGS to revenue (%): 63.586034707766956
SG&A to revenue (%): 50.77587318501221
Free cash flow (dilution-adjusted): 52419.42446043166
Buyback yield (%): 0
Retained earnings: -47733405.035971224
Inventory turnover: 19.863369433706143
Receivables turnover: 1.0942083776728386
Capitalized R&D asset: 0
FCF margin (%): 3.441539456338506
Revenue growth (%): 24.96670108315539
Rule of 40 score: 28.408240539493896
Financial ratios for VLC.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24409448818897636
Shares outstanding: 204532857
Market cap (USD): 49925343.047244094
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VLC.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -29509.55882352941
Operating income: -2004935.294117647
Net income: -1955539.7058823528
Capital expenditures: 1105977.2058823528
Operating cash flow: -1700122.0588235294
Depreciation & amortization: 39808.82352941176
Net tangible assets: 15632408.823529411
Owner earnings: -3021708.0882352935
Return on net tangible assets (%): -19.32976627176685
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 204532857
Book value: 19036014.70588235
P/B ratio: 1.5800765962969574
Market cap (USD): 30078361.32352941
Debt to equity: 0.010238333066810667
Current ratio: 3.109777539115786
Quick ratio: 3.109777539115786
Interest coverage ratio: -164.0818389697918
Free cash flow (dilution-adjusted): -2987681.6176470583
Buyback yield (%): 0
Retained earnings: -15538980.147058822
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.468979980981072
Rule of 40 score: 0
Financial ratios for VLC.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -43412.878787878784
Operating income: -1526793.9393939392
Net income: -1365644.696969697
Capital expenditures: 2034515.1515151514
Operating cash flow: -1021484.0909090908
Depreciation & amortization: 44237.878787878784
Net tangible assets: 18294190.151515152
Owner earnings: -3355921.9696969697
Return on net tangible assets (%): -18.34419529863161
Buffett classification: The Gruesome
Stock price: 0.08333333333333333
Shares outstanding: 204532857
Book value: 21883871.21212121
P/B ratio: 0.7788569300553784
Market cap (USD): 17044404.75
Debt to equity: 0.005728135879786933
Current ratio: 3.933403611797951
Quick ratio: 3.933403611797951
Interest coverage ratio: -114.70506545247581
Free cash flow (dilution-adjusted): -3500003.0303030303
Buyback yield (%): 0
Retained earnings: -17375503.03030303
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.959797088683844
Rule of 40 score: 0
Financial ratios for VLC.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11851851851851851
Shares outstanding: 204532857
Market cap (USD): 24240931.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0